会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 22. 发明申请
    • MODULATION OF MICROBIAL METABOLISM AND/OR GROWTH RATE BY PLANT GROWTH HORMONES
    • 植物生长激素的微生物代谢和/或生长速率的调节
    • WO0014268A9
    • 2000-08-17
    • PCT/US9920491
    • 1999-09-07
    • EDBERG STEPHEN C
    • EDBERG STEPHEN C
    • C12N1/14C12N1/20C12N1/38C12Q1/04C12Q1/18C12Q1/02C12N1/16
    • C12Q1/18C12N1/14C12N1/20C12N1/38C12Q1/04
    • The invention relates to a method of increasing the metabolic rate of bacteria or fungi to produce a defined product, the method including growing the bacteria or fungi in the presence of a plant growth hormone, in an amount sufficient to permit an increase in the metabolic rate of said bacteria or fungi to produce a defined product relative to the production of a defined product by bacteria or fungi grown in the absence of said plant growth hormone. The invention also relates to a method of increasing the growth rate of bacteria or fungi, which method includes growing the bacteria or fungi in the presence of a plant growth hormone selected from the group consisting of: gibberellins, cytokinins, absciscic acids, and ethylenes, in an amount sufficient to permit an increase in the rate of growth of said bacteria or fungi relative to the rate of growth of said bacteria or fungi grown in the absence of said plant growth hormone.
    • 本发明涉及增加细菌或真菌代谢速率以产生限定产品的方法,该方法包括在植物生长激素存在下生长细菌或真菌,其量足以允许代谢率增加 的所述细菌或真菌,以产生相对于在不存在所述植物生长激素的情况下生长的细菌或真菌产生限定产物的限定产物。 本发明还涉及增加细菌或真菌生长速率的方法,该方法包括在选自以下的植物生长激素的存在下生长细菌或真菌:赤霉素,细胞分裂素,脱落酸和乙烯, 其量足以允许相对于在不存在所述植物生长激素的情况下生长的所述细菌或真菌的生长速率来增加所述细菌或真菌的生长速率。
    • 24. 发明申请
    • METHOD AND REAGENTS FOR DETECTING THE PRESENCE OR ABSENCE OF STAPHYLOCOCCUS AUREUS IN A TEST SAMPLE
    • 检测测试样品中存在或不存在白花菜的方法和试剂
    • WO2010151764A1
    • 2010-12-29
    • PCT/US2010/039987
    • 2010-06-25
    • PILOTS POINT LLCEDBERG, Stephen C.
    • EDBERG, Stephen C.
    • C12Q1/14
    • C12Q1/14
    • A presence/absence test for Staphylococcus aureus (S. aureus) involves placing a first generation test sample in a solution that will clot in the presence of S. aureus. The solution contains components that will selectively grow S. aureus and also contains clotting factors that will react with S. aureus, if S. aureus is present in the sample, to clot the solution. Examples of specimen samples that can be tested include nasal swabs and lesion swabs, among others. The test can also be modified to detect the presence or absence of methicillin resistant S. Aureus (MRSA). The addition of micro particles having a size in the range of about 0.1 micron to about 1.0 mm provides localities where the bacteria agglomerate, thereby significantly decreasing the clotting time, and providing a significantly stronger clot. The micro particles can be used in other bacteria tests to accelerate the production of an end result. Such other tests can include a vancomycin-resistant enterococcus test; a Group B Streptococcus test; a test for hemolytic E. coli; and a test for Listeria monocytogenes, to name a few. These tests are all performed in a liquid broth-type reagent mixture and do not necessarily involve clotting of the broth.
    • 金黄色葡萄球菌(金黄色葡萄球菌)的存在/不存在测试涉及将第一代测试样品置于在金黄色葡萄球菌存在下凝结的溶液中。 该溶液含有选择性生长金黄色葡萄球菌的成分,并且还含有凝血因子,如果金黄色葡萄球菌存在于样品中,则会与金黄色葡萄球菌发生反应,以凝固溶液。 可以测试的标本样品的实例包括鼻拭子和病变拭子等。 也可以修改测试以检测耐甲氧西林金黄色葡萄球菌(MRSA)的存在或不存在。 加入尺寸在约0.1微米至约1.0毫米范围内的微粒提供了细菌聚集的地方,从而显着降低凝固时间,并提供明显更强的凝块。 微粒可用于其他细菌测试,以加速最终结果的产生。 这样的其他测试可以包括耐万古霉素肠球菌测试; B组链球菌试验; 溶血性大肠杆菌检测; 和单核细胞增多性李斯特氏菌的检测,仅举几例。 这些测试都是在液体肉汤型试剂混合物中进行的,并不一定涉及肉汤的凝结。